2,353
Views
2
CrossRef citations to date
0
Altmetric
Orphan Drugs

Value-based decision-making for orphan drugs with multiple criteria decision analysis: burosumab for the treatment of X-linked hypophosphatemia

, , , , , , & show all
Pages 1021-1030 | Received 26 Nov 2020, Accepted 14 Mar 2021, Published online: 01 Apr 2021